Wealth Enhancement Advisory Services LLC Buys 8,998 Shares of CorVel Co. (NASDAQ:CRVL)

Wealth Enhancement Advisory Services LLC grew its stake in CorVel Co. (NASDAQ:CRVL - Free Report) by 184.2% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 13,884 shares of the business services provider's stock after purchasing an additional 8,998 shares during the period. Wealth Enhancement Advisory Services LLC's holdings in CorVel were worth $1,545,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds and other institutional investors also recently made changes to their positions in CRVL. LGT Financial Advisors LLC increased its position in CorVel by 200.0% in the 4th quarter. LGT Financial Advisors LLC now owns 255 shares of the business services provider's stock valued at $28,000 after acquiring an additional 170 shares during the period. Bessemer Group Inc. grew its stake in shares of CorVel by 6,350.0% in the fourth quarter. Bessemer Group Inc. now owns 258 shares of the business services provider's stock worth $29,000 after purchasing an additional 254 shares during the last quarter. Jones Financial Companies Lllp acquired a new stake in CorVel in the fourth quarter valued at $37,000. US Bancorp DE raised its position in CorVel by 225.4% during the 4th quarter. US Bancorp DE now owns 384 shares of the business services provider's stock worth $43,000 after purchasing an additional 266 shares during the last quarter. Finally, CIBC Private Wealth Group LLC lifted its holdings in CorVel by 300.0% during the 4th quarter. CIBC Private Wealth Group LLC now owns 480 shares of the business services provider's stock worth $53,000 after buying an additional 360 shares during the period. 51.36% of the stock is owned by institutional investors.

Insider Buying and Selling

In other news, Director Alan Hoops sold 3,000 shares of the business's stock in a transaction on Tuesday, May 27th. The shares were sold at an average price of $113.05, for a total transaction of $339,150.00. Following the completion of the transaction, the director now directly owns 16,688 shares in the company, valued at $1,886,578.40. The trade was a 15.24% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, Director Jeffrey J. Michael sold 16,523 shares of the company's stock in a transaction on Wednesday, April 9th. The stock was sold at an average price of $116.99, for a total transaction of $1,933,025.77. Following the completion of the transaction, the director now directly owns 551,787 shares in the company, valued at approximately $64,553,561.13. The trade was a 2.91% decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders have sold 23,245 shares of company stock worth $2,690,457. 47.57% of the stock is owned by company insiders.

Wall Street Analysts Forecast Growth

Separately, Wall Street Zen upgraded CorVel from a "hold" rating to a "buy" rating in a research report on Friday, April 18th.

CorVel Trading Up 0.1%

CRVL stock traded up $0.09 during trading on Tuesday, reaching $108.29. 182,924 shares of the stock were exchanged, compared to its average volume of 120,177. CorVel Co. has a twelve month low of $76.67 and a twelve month high of $128.61. The firm's 50 day moving average is $111.95 and its 200 day moving average is $116.04. The firm has a market cap of $5.56 billion, a P/E ratio of 63.70 and a beta of 1.02.

CorVel (NASDAQ:CRVL - Get Free Report) last released its quarterly earnings data on Thursday, May 22nd. The business services provider reported $0.51 earnings per share for the quarter. CorVel had a net margin of 10.12% and a return on equity of 32.22%. The firm had revenue of $231.51 million for the quarter.

CorVel Profile

CorVel Corporation provides workers' compensation, auto, liability, and health solutions. It applies technology, including artificial intelligence, machine learning, and natural language processing to enhance the managing of episodes of care and the related health care costs. The company also offers network solutions services, including automated medical fee auditing, preferred provider management and reimbursement, retrospective utilization review, facility claim review, professional review, pharmacy, directed care, clearinghouse, independent medical examination, and inpatient medical bill review services, as well as Medicare solutions.